Press release
Schistosomiasis Drugs Market Size, Share, Recent Developments and Forecast 2024-2031 - Merck & Co., Salvensis, Bayer AG.
Schistosomiasis Drugs Market
Will the Schistosomiasis Drugs Market become the sector's next big opportunity? To find out, delve into the analysis and projections for Schistosomiasis Drugs Market. This market research study offers in-depth insights into the opportunities, challenges, and trends currently shaping the machinery landscape, enabling industry participants to make informed decisions in a dynamic environment. Take advantage of the opportunity in the Schistosomiasis Drugs Market! (2031)
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/schistosomiasis-drugs-market
Schistosomiasis Drugs Market was valued at USD 70.4 million in 2021. It is forecasted to reach USD million by 2031, growing at a CAGR of 3.8% during the forecast period (2024-2031).
Key Growth Drivers in Schistosomiasis Drugs Market:
Drugs for schistosomiasis, a parasitic disease caused by trematode worms of the genus Schistosoma, primarily include praziquantel. This medication is effective in treating the infection by targeting the adult worms and causing their paralysis and disintegration. Praziquantel is the most commonly prescribed treatment, particularly in endemic areas where schistosomiasis is prevalent. Research is ongoing to develop additional therapies and improve treatment regimens, especially for drug-resistant strains of the parasite. Effective management of schistosomiasis is crucial for public health, particularly in regions where the disease is endemic.
DataM Intelligence profiles some of the most reputed organizations present in the Schistosomiasis Drugs market. They are as follows:
Chemos GmbH & Co. KG, Shin Poong Pharma. Co. Ltd., Meher Distributors Pvt. Ltd., Merck & Co., Salvensis, Bayer AG, LondonPharma Ltd, Merck & Co., Inc., 3S Corporation Kancera AB, Taj Pharmaceuticals Ltd., Avanscure Lifesciences Pvt. Ltd, CBC Pharma., VHB Life Science Inc., Samarth Pharma Pvt. Ltd., Taj Pharmaceuticals Ltd., and Egyptian International Pharmaceuticals Industries Co SAE.
Segment Covered in the Schistosomiasis Drugs Market:
By Site: Intestinal Schistosomiasis, Urogenital Schistosomiasis.
By Species Type: Schistosoma mansoni, Schistosoma japonicum, Schistosoma mekongi, Schistosoma guineensis, Schistosoma haematobium.
By Drug Type: Praziquantel (Biltricide), Oxamniquine (Vansil), Metrifonate, Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others.
Regional Analysis:
The global Schistosomiasis Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
Key Developments
In January 2020, Merck, a prominent science and technology company, achieved a significant milestone by donating 1 billion tablets of praziquantel to the World Health Organization (WHO). Praziquantel is the standard medication used to treat schistosomiasis, a neglected tropical disease (NTD) that predominantly affects children in impoverished rural areas. This major contribution is part of Merck's long-standing commitment to combat schistosomiasis, starting in 2007, and has enabled the treatment of approximately 400 million school-aged children in Sub-Saharan Africa. The donation is a key step towards eliminating this debilitating disease, which continues to impact vulnerable populations worldwide.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=schistosomiasis-drugs-market
Regional Analysis:
The global Schistosomiasis Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Schistosomiasis Drugs Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Points Covered:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Schistosomiasis Drugs market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Schistosomiasis Drugs Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Schistosomiasis Drugs market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Schistosomiasis Drugs Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/schistosomiasis-drugs-market
FAQ's
Q.1. What are the primary drivers of the Schistosomiasis Drugs Industry?
Q.2. What are the main factors propelling and impeding the growth of the Schistosomiasis Drugs market?
Q.3. What are the general structure, risks, and opportunities of the market?
Q.4. How do the prices, revenue, and sales of the leading Schistosomiasis Drugs market firms compare?
Q.5. What are the main segments of the market and how is it divided up?
Q.6. Which companies dominate the market, and what percentage of the market do they control?
Q.7. What trends are influencing the Schistosomiasis Drugs market now and in the future?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Schistosomiasis Drugs Market Size, Share, Recent Developments and Forecast 2024-2031 - Merck & Co., Salvensis, Bayer AG. here
News-ID: 3699513 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Oil & Gas Cloud Applications Market to hit $31.78Bn by 2032,fueled by upstream d …
The Oil and Gas Cloud Application Market is set for significant expansion, growing at a CAGR of 12.84% during the forecast period 2025-2032. According to DataM Intelligence, the market reached US$12.09 billion in 2024 and is projected to reach US$31.78 billion by 2032. This robust growth is fueled by the increasing adoption of cloud solutions across upstream, midstream, and downstream operations as oil and gas companies seek to modernize legacy…
United States & Japan Healthcare Supply Chain Management Market Forecast: Digita …
The Global Healthcare Supply Chain Management Market reached US$ 3. 41 billion in 2024 and is expected to reach US$ 9.48 billion by 2033, growing at a CAGR of 11.7% during the forecast period 2025-2033.
The Healthcare Supply Chain Management market involves the coordination, tracking, and optimization of medical products, equipment, and pharmaceuticals from manufacturers to healthcare providers. Efficient supply chain management ensures timely delivery, cost control, inventory optimization, and patient…
United States and Japan Telehealth Market Insights: Remote Patient Monitoring, V …
The Telehealth Market reached US$ 118.25 billion in 2024 and is expected to reach US$ 699.95 billion by 2033, growing at a CAGR of 16.7% during the forecast period 2025-2033.
The telehealth market involves the delivery of healthcare services remotely through digital communication technologies such as video calls, apps, and remote monitoring tools. It enables real-time consultations, chronic disease management, and mental health support, expanding access to care, especially in rural…
United States & Japan Agrivoltaics Market Trends: Adoption of Bifacial Panels, A …
Global Agrivoltaics Market reached US$ 4.32 billion in 2024 and is expected to reach US$ 8.41 billion by 2032, growing with a CAGR of 8.68% during the forecast period 2025-2032, according to DataM Intelligence report.
The Agrivoltaics market involves integrating solar photovoltaic (PV) systems with agricultural land to simultaneously generate renewable energy and cultivate crops. This dual-use approach maximizes land efficiency, improves crop yields in certain conditions, and supports sustainable energy…
More Releases for Schistosomiasis
Schistosomiasis Market Share, Epidemiology, Analysis & Trends 2023-2033
Schistosomiasis Market Report Overview:
Report Attribute Details
Base Year 2022
Forecast Years …
Schistosomiasis Pipeline Featuring 3+ Companies Expected to Change the Pace of t …
"The infectious form of the parasite, known as cercariae, emerge from the snail into the water. You can become infected when your skin comes in contact with contaminated freshwater. Most human infections are caused by Schistosoma mansoni, S. haematobium, or S. japonicum"
The drug is described in detail in the Schistosomiasis pipeline report, along with its mechanism of action, Schistosomiasis clinical trials, Schistosomiasis NDA approvals (if any), and product development activities…
Drugs for Schistosomiasis Market - key players covered:EIPICO, Chandra Bhagat Ph …
Los Angeles, United State, –The report titled Global Drugs for Schistosomiasis Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Drugs for Schistosomiasis market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of…
Schistosomiasis Therapeutics- Pipeline Analysis 2018
Schistosomiasis is an acute and chronic disease caused by parasitic worms of the genus Schistosoma, during routine domestic, occupational, agricultural, and recreational activities, which involves infested water exposure.
Download the sample report @ https://www.pharmaproff.com/request-sample/1070
School children are more prone to schistosomiasis due to lack of hygiene and certain play habits, such as swimming or fishing in infested water. Symptoms of schistosomiasis are caused by the body’s reaction to the worms' eggs.…
Schistosomiasis-Pipeline Review H2 2018
Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle pain.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Schistosomiasis-Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Schistosomiasis (Infectious Disease), complete with analysis by…
Schistosomiasis Treatment Market Size, Outlook, and Opportunity Analysis, 2018-2 …
Schistosomiasis is a disease caused by infection with freshwater parasitic worms. It can be acute or chronic infection mainly caused by parasitic worm’s blood flukes (trematode worms). There are two forms of schistosomiasis, such as intestinal and urogenital. According to the World Health Organization (WHO) reports in 2017, urogenital schistosomiasis is a high risk factor for the transmission of HIV infection in women. People usually get infected during agriculture, domestic,…
